22nd Century Group, Inc. (XXII)

$1.52

-0.11 (-6.75%)
Rating:
Recommendation:
Neutral
Symbol XXII
Price $1.52
Beta 1.603
Volume Avg. 2.36M
Market Cap 326.473M
Shares () -
52 Week Range 1.42-4.05
1y Target Est -
DCF Unlevered XXII DCF ->
DCF Levered XXII LDCF ->
ROE -57.95% Strong Sell
ROA -36.68% Strong Sell
Operating Margin -
Debt / Equity 20.13% Neutral
P/E -
P/B 2.78 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest XXII news


Mr. Clifford Fleet
Consumer Defensive
Tobacco
NASDAQ Capital Market

22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.